👉An interesting paper :
"HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms."
" (...) The present study shows, for the first time, that the HERV-W ENV protein can still be actively expressed long after SARS-CoV-2 infection is resolved in post-COVID-19 condition patients.(...)"
There's a P2 clinical trial enrolling:
https://clinicaltrials.gov/ct2/show/NCT05497089
#Post-Covid #LongCovid #SARS-CoV-2 #Retrovirus #PHERV-W env #Temelimab #ClinicalTrial
#post #LongCovid #sars #retrovirus #pherv #temelimab #clinicaltrial
Bonjour,
Pour le #CovidLong on parle dans cette courte vidéo de l'essai clinique de #phase2 en cours ciblant la #pHERV-w enveloppe chez certains malades ayant eu la #COVID19
🔗🔽
En 🇫🇷
https://youtu.be/ulIOVKTfjME
En 🇬🇧 https://youtu.be/OwbC5e0c_7k
En 🇪🇸
https://youtu.be/03WYfkwC-zs
#Après-J20
🔗 Lien vers l'étude/ The study
https://twitter.com/iguessous/status/1591705247474454528?t=t9eCU0RA_N27iYjRbh53nw&s=19
🔗email : etude.longcovid@hcuge.ch
#CovidLong #phase2 #pherv #COVID19 #apres